(Q43076662)

English

Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol

scientific article published on 26 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 November 2017

Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol (English)

1 reference

Europe PubMed Central

13 November 2017

1 reference

based on heuristic

inferred from title

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

2

object named as

Claus Belka

1 reference

Europe PubMed Central

13 November 2017

author name string

Bernhard Berger

1

1 reference

Europe PubMed Central

13 November 2017

Martin Weinmann

3

1 reference

Europe PubMed Central

13 November 2017

Michael Bamberg

4

1 reference

Europe PubMed Central

13 November 2017

Wilfried Budach

5

1 reference

Europe PubMed Central

13 November 2017

Thomas Hehr

6

1 reference

Europe PubMed Central

13 November 2017

publication date

26 April 2010

1 reference

Europe PubMed Central

13 November 2017

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

13 November 2017

186

1 reference

Europe PubMed Central

13 November 2017

5

1 reference

Europe PubMed Central

13 November 2017

255-261

1 reference

Europe PubMed Central

13 November 2017

https://scigraph.springernature.com/pub.10.1007/s00066-010-2082-9

0 references

Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2082-9

21 January 2018

Salvage re-irradiation for recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2082-9

21 January 2018

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2082-9

21 January 2018

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2082-9

21 January 2018

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2082-9

21 January 2018

IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2082-9

21 January 2018

Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2082-9

21 January 2018

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review on re-irradiation for recurrent and second primary head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The chemoradiation paradigm in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helical tomotherapy. Experiences of the first 150 patients in Heidelberg

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel in the management of patients with head and neck squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curative brachytherapy for recurrent/residual tongue cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reirradiation in squamous cell head and neck cancer: recent developments and future directions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for different chemotherapeutic and radiation therapy strategies in cancer management

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20437016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-010-2082-9

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43076662&oldid=1980117193"